Lorcainide
Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions, ventricular tachycardiac and Wolff-Parkinson-White syndrome. Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001. It has a half-life of 8.9 +- 2.3 hrs which may be prolonged to 66 hrs in people with cardiac disease.
Wikipage redirect
primaryTopic
Lorcainide
Lorcainide (Lorcainide hydrochloride) is a Class 1c antiarrhythmic agent that is used to help restore normal heart rhythm and conduction in patients with premature ventricular contractions, ventricular tachycardiac and Wolff-Parkinson-White syndrome. Lorcainide was developed by Janssen Pharmaceutica (Belgium) in 1968 under the commercial name Remivox and is designated by code numbers R-15889 or Ro 13-1042/001. It has a half-life of 8.9 +- 2.3 hrs which may be prolonged to 66 hrs in people with cardiac disease.
has abstract
Lorcainide (Lorcainide hydroch ...... n people with cardiac disease.
@en
CAS number
59729-31-6
ChEMBL
FDA UNII code
KGJ2T0N7IQ
KEGG
PubChem
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
997,802,876
Link from a Wikipage to another Wikipage
ATC prefix
ATC suffix
BC07
@en
CAS number
ChEMBL
ChemSpiderID
elimination half-life
IUPAC name
N--N--2-phenylacetamide
@en
KEGG
D08020
@en
protein bound
PubChem
SMILES
Clc3ccccc3
@en
StdInChIKey
XHOJAWVAWFHGHL-UHFFFAOYSA-N
@en
UNII
KGJ2T0N7IQ
@en
Verifiedfields
changed
@en
verifiedrevid
462,093,837
wikiPageUsesTemplate
subject
hypernym
comment
Lorcainide (Lorcainide hydroch ...... n people with cardiac disease.
@en
label
Lorcainide
@en